These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10816702)

  • 1. The stage is set for the diffusion of positron emission tomography (PET) in oncology.
    Morris JG
    Med J Aust; 1999 Nov; 171(10):527-8. PubMed ID: 10816702
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner.
    Hicks RJ; Binns DS; Fawcett ME; Ware RE; Kalff V; McKenzie AF; Zalcberg JP; Peters LJ
    Med J Aust; 1999 Nov; 171(10):529-32. PubMed ID: 10816703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoro-2-deoxy-glucose positron emission tomography in oncology: are we there yet?
    Khafagi FA
    Intern Med J; 2001; 31(1):3-4. PubMed ID: 11478354
    [No Abstract]   [Full Text] [Related]  

  • 4. An approach to demonstrating cost-effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography.
    Miles KA
    Australas Radiol; 2001 Feb; 45(1):9-18. PubMed ID: 11259966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical use of PET--where are we now?
    Cook GJ
    Br J Radiol; 2001 May; 74(881):399-401. PubMed ID: 11388986
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in FDG PET probes in surgical oncology.
    Essner R; Daghighian F; Giuliano AE
    Cancer J; 2002; 8(2):100-8. PubMed ID: 11999944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography and the Hungarian PET program].
    Trón L
    Orv Hetil; 2002 May; 143(21 Suppl 3):1235-40. PubMed ID: 12077904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Positron emission tomography in the Netherlands: need to expand the capacity].
    Comans EF; Smit EF
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1817-9. PubMed ID: 12382364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guest editorial: the conception of FDG-PET imaging.
    Alavi A; Reivich M
    Semin Nucl Med; 2002 Jan; 32(1):2-5. PubMed ID: 11839067
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of clinical PET.
    Maisey MN
    Br J Radiol; 2002 Nov; 75 Spec No():S1-5. PubMed ID: 12523320
    [No Abstract]   [Full Text] [Related]  

  • 12. PET scanning in malignancy: infant, adolescent or mature citizen?
    Brennan MF
    Ann Surg; 2001 Mar; 233(3):320-1. PubMed ID: 11224618
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical oncologic positron emission tomography: an introduction.
    Turkington TG; Coleman RE
    Semin Roentgenol; 2002 Apr; 37(2):102-9. PubMed ID: 12134363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of positron emission tomography in oncology.
    Scott AM
    Intern Med J; 2001; 31(1):27-36. PubMed ID: 11478353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [2002 Standards, Options and Recommendations for the use of [18F]-FDG (PET-FDG) in cancerology].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S1-109. PubMed ID: 12744225
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of tumor response using [18F]-2-fluoro-2-deoxy-D-glucose and positron-emission tomography.
    Lammertsma AA
    J Clin Pharmacol; 2001 Jul; 41(S7):104S-106S. PubMed ID: 11452713
    [No Abstract]   [Full Text] [Related]  

  • 17. Positron emission tomography (PET) in diagnostic oncology: is it a necessary tool today?
    Price P
    Eur J Cancer; 2000 Apr; 36(6):691-3. PubMed ID: 10762740
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
    Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
    Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
    Soepenberg O
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1979-80. PubMed ID: 11048563
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomography (PET)--evaluation of 'indeterminate pulmonary lesions'.
    Wong WL; Campbell H; Saunders M
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):123-8. PubMed ID: 12069119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.